Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Dec 14;54(3):474–478. doi: 10.1093/jrr/rrs121

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2012. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 3. — Thrombocytopenia observed in patients treated with innovator and generic cisplatin formulations. (a) All patients. (b–d) Patients received 3 (b), 4 (c) and 5 (d) cycles of chemotherapy. Toxicity was evaluated by the Common Terminology Criteria for Adverse Events ver. 4.0 (CTCAE) grades. Incidences of Grade 1–2 and Grade 0 thrombocytopenia were compared.